OIAM
BIIB icon

OFI Invest Asset Management’s Biogen BIIB Stock Holding History

OFI Invest Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-750
Closed -$80.2K – 304
2025
Q2 		$80.2K Buy
750
+283
+61% +$35.3K ﹤0.01% 293
2025
Q1 		$59.2K Buy
467
+248
+113% +$35.5K ﹤0.01% 328
2024
Q4 		$32.3K Buy
+219
New +$36.9K ﹤0.01% 359
2024
Q2 		$34.2K Buy
158
+43
+37% +$9.35K ﹤0.01% 296
2024
Q1 		$23K Buy
115
+12
+12% +$2.81K ﹤0.01% 285
2023
Q4 		$24.1K Sell
103
-3
-3% -$737 ﹤0.01% 270
2023
Q3 		$25.7K Buy
+106
New +$28.4K ﹤0.01% 178

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

OFI Invest Asset Management's BIIB Position: Q3 2025 in Review

OFI Invest Asset Management sold out of Biogen (BIIB) in Q3 2025, closing a stake of 750 shares — an estimated $80.2K sold.

OFI Invest Asset Management first reported a position in BIIB in Q3 2023 and held it in 7 quarters. The position peaked at $80.2K in Q2 2025. 907 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • OFI Invest Asset Management reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • OFI Invest Asset Management sold 750 Biogen shares in Q3 2025, an estimated $80.2K.
  • OFI Invest Asset Management first reported a position in Biogen in Q3 2023 and held it in 7 quarters.
  • OFI Invest Asset Management's Biogen position peaked at $80.2K in Q2 2025.
  • 907 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on OFI Invest Asset Management's 13F filing for Q3 2025, filed 14 Oct 2025.